Lean or non-obese nonalcoholic fatty liver disease patients: Are they really lean?

키워드

참고문헌 (24)

1. 한유진, "Fatty Liver & Diabetes Statistics in Korea: Nationwide Data 2009 to 2017", Diabetes and Metabolism Journal, 47(3), pp.347~355 (2023), 대한당뇨병학회[DOI]
2. Ye Q, "Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease : a systematic review and meta-analysis", Lancet Gastroenterol Hepatol, 5, pp.739~752 (2020)
3. Fan JG, "New trends on obesity and NAFLD in Asia", J Hepatol, 67, pp.862~873 (2017)
4. Hong-Kyu Kim, "Association of visceral fat obesity, sarcopenia, and myosteatosis with non-alcoholic fatty liver disease without obesity", Clinical and Molecular Hepatology, 29(4), pp.987~1001 (2023), 대한간학회
5. Andreasson A, "Waist", hip ratio better predicts development of severe liver disease within 20 years than body mass index : A population-based cohort study, 2017, pp.15, 1294~1301
6. Han E, "Muscle fat contents rather than muscle mass determines nonalcoholic steatohepatitis and liver fibrosis in patients with severe obesity", Obesity(Silver Spring), 30, pp.2440~2449 (2022)
7. Sae Kyung Joo, "Interaction between sarcopenia and nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 29, pp.68~78 (2023), 대한간학회
8. Hsieh YC, "Myosteatosis, but not sarcopenia, predisposes NAFLD subjects to early steatohepatitis and fibrosis progression", Clin Gastroenterol Hepatol, 21, pp.388~397 (2023)
9. Goodpaster BH, "Skeletal muscle lipid content and insulin resistance : evidence for a paradox in endurance-trained athletes", J Clin Endocrinol Metab, 86, pp.5755~5761 (2001)
10. 김지윤, "Associations between Weight-Adjusted Waist Index and Abdominal Fat and Muscle Mass: Multi-Ethnic Study of Atherosclerosis", Diabetes and Metabolism Journal, 46(5), pp.747~755 (2022), 대한당뇨병학회[DOI]
11. Kim D, "Body fat distribution and risk of incident and regressed nonalcoholic fatty liver disease", Clin Gastroenterol Hepatol, 14, pp.132~138 (2016)
12. 양예슬, "Obesity Fact Sheet in Korea, 2021: Trends in Obesity Prevalence and Obesity-Related Comorbidity Incidence Stratified by Age from 2009 to 2019", Journal of Obesity & Metabolic Syndrome, 31(2), pp.169~177 (2022), 대한비만학회
13. 한유진, "Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases", Diabetes and Metabolism Journal, 41(6), pp.430~437 (2017), 대한당뇨병학회[DOI]
14. Leung JC, "Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients", Hepatology, 65, pp.54~64 (2017)
15. Younes R, "Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean : time for reappraisal of BMI-driven approach?", Gut, 71, pp.382~390 (2022)
16. Ho Soo Chun, "Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?", Clinical and Molecular Hepatology, 29(2), pp.377~380 (2023), 대한간학회
17. Wah-Kheong Chan, "Comparison between obese and non-obese nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 29, pp.58~67 (2023), 대한간학회
18. Hagström H, "Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease : A long-term followup study", Hepatol Commun, 2, pp.48~57 (2017)
19. Kim Yuna, "Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease", Gut and Liver, 16(2), pp.290~299 (2022), 거트앤리버 소화기연관학회협의회[DOI]
20. Lee YH, "Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance : Nationwide surveys(KNHANES 2008-2011)", J Hepatol, 63, pp.486~493 (2015)
21. Han E, "Nonalcoholic fatty liver disease and sarcopenia are independently associated with cardiovascular risk", Am J Gastroenterol, 115, pp.584~595 (2020)
22. Xin-Lei Zhang, "Lifestyle Interventions for Non-Obese Patients Both with, and at Risk, of Non-Alcoholic Fatty Liver Disease", Diabetes and Metabolism Journal, 46(3), pp.391~401 (2022), 대한당뇨병학회[DOI]
23. Han E, "Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B", Aliment Pharmacol Ther, 48, pp.300~312 (2018)
24. Chun HS, "Association of physical activity with risk of liver fibrosis, sarcopenia, and cardiovascular disease in nonalcoholic fatty liver disease", Clin Gastroenterol Hepatol, 21, pp.358~369 (2023)

관련 논문AI추천